United Mitochondrial Disease Foundation
Overview
United Mitochondrial Disease Foundation is a non-profit organization that promotes research and education for the diagnosis, treatment, and cure of mitochondrial disorders, and provides funding to companies developing therapies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Khondrion | May 2025 | VC Round | Co-investor |
| Pretzel Therapeutics | Jul 2025 | VC Round | Lead |
| NAPIGEN, INC. | Jul 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is United Mitochondrial Disease Foundation based?
United Mitochondrial Disease Foundation is headquartered in Pittsburgh, Pennsylvania, United States.
When was United Mitochondrial Disease Foundation founded?
United Mitochondrial Disease Foundation was founded in 1995.
How many portfolio companies does United Mitochondrial Disease Foundation have?
United Mitochondrial Disease Foundation has 3 portfolio companies in Caplight's dataset.
What are some companies in United Mitochondrial Disease Foundation's portfolio?
Portfolio companies visible on Caplight include Khondrion, Pretzel Therapeutics, NAPIGEN, INC..
What was United Mitochondrial Disease Foundation's most recent investment shown here?
United Mitochondrial Disease Foundation's most recent investment in this portfolio sample was in Pretzel Therapeutics in 2025.
What sectors does United Mitochondrial Disease Foundation focus on?
United Mitochondrial Disease Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does United Mitochondrial Disease Foundation focus on?
Stage focus information for United Mitochondrial Disease Foundation is not publicly available.
What is United Mitochondrial Disease Foundation's AUM?
United Mitochondrial Disease Foundation's assets under management are estimated between $6.4M and $6.4M.